Read news as it happens
Create a Rediffmail account
Subscribe via RSS
Before Obama visit, US drug firms lobby for ease of doing business
Several US-based firms, sources say, are lobbying with regulatory authorities over the price-control framework, which is hurting their margins. Weeks before US President Barack Obama’s visit......
FIPB clears GlaxoSmithKline's Rs 6,400-crore FDI proposal
FIPB on Monday cleared Rs 6,400-crore (Rs 64-billion) foreign direct investment proposal of GlaxoSmithKline to acquire additional 24.33 per cent stake in its India arm. "The proposal of......
All pharma M&As to be cleared by CCI: Plan panel group
A Planning Commission expert groupon Tuesdayrecommended that all mergers and acquisitions (M&As) in the pharmaceutical industry should be cleared by competition watchdog, CCI to ensure that such......
Life saving move! India rejects Abbot's HIV drug patent
India has rejected a drug patent application of a United States multinational pharma company, paving the way for easy access to an important life-saving medication for HIV patients across the......
Wockhardt-Abbot deal gets high court go-ahead
Wockhardt's efforts to restructure its operations have received a boost with the Bombay high court declining to grant an injunction sought by a section of its investors to stall the divestment of......
bharatiya janata party
united progressive alliance
national democratic alliance
rashtriya swayamsevak sangh
central bureau of investigation
Top Coverage News
Coming to India and making
Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
India, through the eye of a camera
Commonwealth Games - 2014
The defence coverage of Rediff.com
The ISIS war in Iraq
Office email App
© 2015 Rediff.com
India Abroad weekly